Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Eboo Pharmaceuticals Inc.
DescriptionDelta Agonist/Mu Antagonist (DAMA)
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor antagonist; Delta opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat levodopa-induced dyskinesia in patients with Parkinson's disease (PD); Treat Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today